March 6, 2026 — Building on its leadership in cardiac MR, Philips has received FDA 510(k) clearance for SmartHeart, an AI-powered cardiac MR planning solution designed to simplify one of the most ...
March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...
March 10, 2026 — HeartHero has announced that its Premarket Approval (PMA) application for Elliot, the company’s ...
March 6, 2026 — Building on its leadership in cardiac MR, Philips has received FDA 510(k) clearance for SmartHeart, an ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...
March 2, 2026 — Ascend Cardiovascular has launched its re-imagined pediatric cardiology product, a comprehensive ...
March 4, 2026 — Inflo Health has launched a comprehensive cardiology suite designed to address care management gaps ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...
March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...
March 3, 2026 — MedDream will present its cloud-native, AI-ready universal DICOM viewer in the Amazon Web Services (AWS) ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Feb. 27, 2026 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s CardioMEMS Hero device — a pulmonary ...
Feb. 25, 2026 — Gentuity LLC, a medical technology company specializing in next-generation intravascular imaging devices ...
Feb. 26, 2026 — Eko Health has partnered with Wayne General Hospital in Wayne County, Mississippi, to deploy SENSORA, an ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...
Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...
Feb. 19, 2026 — Preliminary results from an Italian registry describe the risk profile of women experiencing acute ...
March 11, 2026
